ENTRY       D11306                      Drug
NAME        Flotetuzumab (USAN/INN)
FORMULA     C2618H4040N704O813S16
EXACT_MASS  58861.1959
MOL_WEIGHT  58897.3592
SEQUENCE    (A chain)
            DFVMTQSPDS LAVSLGERVT MSCKSSQSLL NSGNQKNYLT WYQQKPGQPP KLLIYWASTR
            ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQNDYSY PYTFGQGTKL EIKGGGSGGG
            GEVQLVESGG GLVQPGGSLR LSCAASGFTF STYAMNWVRQ APGKGLEWVG RIRSKYNNYA
            TYYADSVKDR FTISRDDSKN SLYLQMNSLK TEDTAVYYCV RHGNFGNSYV SWFAYWGQGT
            LVTVSSGGCG GGKVAALKEK VAALKEKVAA LKEKVAALKE
            (B chain)
            XAVVTQEPSL TVSPGGTVTL TCRSSTGAVT TSNYANWVQQ KPGQAPRGLI GGTNKRAPWT
            PARFSGSLLG GKAALTITGA QAEDEADYYC ALWYSNLWVF GGGTKLTVLG GGGSGGGGEV
            QLVQSGAELK KPGASVKVSC KASGYTFTDY YMKWVRQAPG QGLEWIGDII PSNGATFYNQ
            KFKGRVTITV DKSTSTAYME LSSLRSEDTA VYYCARSHLL RASWFAYWGQ GTLVTVSSGG
            CGGGEVAALE KEVAALEKEV AALEKEVAAL EK
            (Disulfide bridge: A23-A94, A143-A219, A249-B241, B22-B90, B140-B214)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of hematologic malignancies
TARGET      IL3RA (CD123) [HSA:3563] [KO:K04737]
            CD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]
  PATHWAY   hsa04640(3563+915+916+917)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL3RA (CD123)
                 D11306  Flotetuzumab (USAN/INN)
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3
                 D11306  Flotetuzumab (USAN/INN)
DBLINKS     CAS: 1664355-28-5
            PubChem: 384585284
///
